These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 761378)

  • 21. [Determination of digoxin in serum. Comparison of radioimmunoassay and a heterogeneous enzyme immunoassay (author's transl)].
    Borner K; Rietbrock N
    J Clin Chem Clin Biochem; 1978 Jun; 16(6):335-42. PubMed ID: 353220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disposable-column radioimmunoassay for serum digoxin with less interference from metabolites and endogenous digitalis-like factors.
    Longerich L; Vasdev S; Johnson E; Gault MH
    Clin Chem; 1988 Nov; 34(11):2211-6. PubMed ID: 2846204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interference between eplerenone and digoxin in fluorescence polarization immunoassay, microparticle enzyme immunoassay, and affinity column-mediated immunoassay.
    Yamada T; Suzuki K; Iguchi K; Kanada Y; Kato R; Ijiri Y; Nishihara M; Murakami S; Hayashi T; Tamai H; Tanaka K
    Ther Drug Monit; 2010 Dec; 32(6):774-7. PubMed ID: 20625353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of digoxin concentrations in serum by fluorescence polarization immunoassay: an evaluation.
    Ferreri LF; Raisys VA; Opheim KE
    J Anal Toxicol; 1984; 8(3):138-40. PubMed ID: 6376949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sources of error in the radioimmunochemical determination of digoxin in serum].
    Müller H; Graul EH
    Nucl Med (Stuttg); 1975 Dec; 14(4):381-9. PubMed ID: 1215215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. False-positive serum digoxin concentrations determined by three digoxin assays in patients with liver disease.
    Frisolone J; Sylvia LM; Gelwan J; Pal S; Pellechia C
    Clin Pharm; 1988 Jun; 7(6):444-9. PubMed ID: 3402179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Letter: Digoxin immunoassay with use of [3H]digoxin vs. [125I]tyrosine-methyl-ester of digoxin.
    Pippin SL; Marcus FI
    Clin Chem; 1976 Feb; 22(2):286-7. PubMed ID: 1248138
    [No Abstract]   [Full Text] [Related]  

  • 28. Digoxin radioimmunoassay: a comparison of the assay performances using tritiated and 125I radioiodinated tracers.
    Barbieri U; Gandolfi C
    Clin Chim Acta; 1977 Jun; 77(3):257-67. PubMed ID: 872427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spironolactone metabolite causes falsely increased progesterone in the Abbott Architect immunoassay.
    Sarpong KAN; Hee Kim S; McCartney CR; Wiencek JR; Bazydlo LAL
    Clin Biochem; 2024 Apr; 126():110747. PubMed ID: 38484829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of radioimmunoassay for measurement of serum digoxin in digitalized patients using novel anti-digoxin antiserum.
    Ikeda Y; Araki T; Takimoto H; Fujii Y
    Biol Pharm Bull; 2002 Apr; 25(4):422-5. PubMed ID: 11995917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum digoxin levels using an 125I-labelled antigen: Validation of method and observations on cardiac patients.
    Taubert K; Shapiro W
    Am Heart J; 1975 Jan; 89(1):79-86. PubMed ID: 1109556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Digoxin radioimmunoassay: Part II--Measurement & Comparison of tritium method with 125I-labelled radioimmunoassay kits.
    Vemuri S; Sambamurthy K
    Indian J Exp Biol; 1980 Jul; 18(7):669-71. PubMed ID: 7429576
    [No Abstract]   [Full Text] [Related]  

  • 33. Simultaneous determination of canrenone, digoxin and tolvaptan by UHPLC-MS/MS: application in heart failure patients.
    Guo P; Liang Q; Zheng J; Chen J; Guan Y; Ding L; Jiang F; Chen X; Huang M; Chen A; Zhong G
    Bioanalysis; 2020 May; 12(9):569-582. PubMed ID: 32469241
    [No Abstract]   [Full Text] [Related]  

  • 34. [A simplified radioimmunoassay for digoxin determination using a 125-j-labelled, solid-phase kit (author's transl)].
    Doering W; Blümel E
    Klin Wochenschr; 1978 May; 56(10):497-502. PubMed ID: 651281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A dry-strip immunometric assay for digoxin on the Ames Seralyzer.
    Iosefsohn M; Soldin SJ; Hicks JM
    Ther Drug Monit; 1990 Mar; 12(2):201-5. PubMed ID: 2315978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measuring endogenous digoxin-like substance and exogenous digoxin in the serum of low-birth-weight infants.
    Ng PK; LeGatt D; Coates J; Collins-Nakai RL
    Am J Hosp Pharm; 1985 Sep; 42(9):1977-9. PubMed ID: 3901741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors of importance for valid digitalis assays particularly for the determination of digoxin in plasma and urine.
    Molin L
    Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 4():1-62. PubMed ID: 3739734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variability among commercially available digoxin radioimmunoassay kits in cross reactivity to dihydrodigoxin.
    Kramer WG; Kinnear NL; Morgan HK
    Clin Chem; 1978 Jan; 24(1):155-7. PubMed ID: 618648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory problems in digoxin radioimmunoassay.
    Ravel R; Schall RF; Espinola A
    Am J Med Technol; 1977 Oct; 43(10):994-1003. PubMed ID: 920750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interference of spironolactone in 11-doexycorticosterone radioassays.
    Tan SY; Mulrow PJ
    J Clin Endocrinol Metab; 1975 Oct; 41(4):791-2. PubMed ID: 1176585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.